Price is the single most powerful lever to increase a company’s profits. So why are so many companies still holding onto the one-size-fits-all traditional cost-plus pricing logic?
As many pharmaceutical and biotech companies strategically outsource their product development and manufacturing, this article advises CDMOS on how to capitalise on the trend through effective monetisation. Key to success is intuitive offer design and a value-based pricing approach.
